|
Ensysce Biosciences Inc (ENSC) |
|
Ensysce Biosciences Inc
ENSC's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Ensysce Biosciences Inc 's sales fell
by -76.98 % in II. Quarter 2024 from the same quarter a year ago.
Major Pharmaceutical Preparations industry recorded
growth of revenues by 5.17 %
Ensysce Biosciences Inc net loss decreased from $-2 millions, to $-2 millions in II. Quarter 2024,
• More on ENSC's Growth
|
|
Ensysce Biosciences Inc realized a net loss in trailing twelve months.
Ensysce Biosciences Inc realized cash reduction of $ -0.04 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 0.95.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.77.
• More on ENSC's Valuation
|
|
|
|
|
Ensysce Biosciences Inc realized net loss in trailing twelve months.
Ensysce Biosciences Inc realized cash outflow of $ -0.04per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 0.95.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.77.
Ensysce Biosciences Inc Price to Book Ratio is at 1.06 lower than Industry Avg. of 85.07. and higher than S&P 500 Avg. of 0
• More on ENSC's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2024 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com